Scienture Holdings Inc

This management proposal asks stockholders to cast a non-binding advisory vote to approve the compensation paid to the named executive officers as disclosed in the proxy statement. Management frames the request as a statutory, mandatory advisory vote under Section 14A (a “say-on-pay”), and the board states that the company’s programs tie executive pay to operational performance and align management with stockholder interests. The board also notes that stockholders previously voted to hold this advisory vote annually and that the vote is non-binding but will be considered by the board and the compensation committee when setting future compensation. Company disclosure shows meaningful equity awards granted in 2025 to newly appointed co‑CEOs that materially increased compensation actually paid despite deteriorating TSR and a net loss in 2025, creating a potential pay-for-performance disconnect that investors may scrutinize. The proposal provides shareholders an opportunity to voice support or concern with the size, structure, or timing of equity and other awards; a negative vote would signal dissatisfaction and could prompt changes to plan design or grant practices. Management recommends a “FOR” vote on the basis that the program is appropriately designed and working to align interests, but it acknowledges the advisory nature of the vote. Given the company’s recent governance actions (co-CEO appointments, equity grants that vested in 2025, and prior strong shareholder support in 2024), investors should weigh alignment benefits of equity grants against the demonstrated disconnect between pay and TSR/net income in 2025. The outcome is non-binding, but a substantial ‘‘against’’ vote would be meaningful and could influence future compensation decisions, disclosures, and shareholder engagement.

This management proposal asks shareholders to grant the board discretionary authority to adjourn the annual meeting to another time or place to solicit additional proxies if there are insufficient votes to approve the proposals or to establish a quorum. The board frames this as a procedural mechanism to ensure that substantive proposals can be approved by shareholders and that the meeting can be reconvened to solicit additional votes, which is a common governance practice. Approval requires a majority of votes cast and, if passed, allows management to extend solicitation efforts, including contacting previously voting stockholders for changed instructions. From a governance perspective, the proposal is pragmatic—adjournment can prevent the costs and disruption of redoing governance actions or failing to implement approved transactions due to technicalities—but it also grants management tactical flexibility that, in rare circumstances, could be used to seek more favorable outcomes through extended solicitation. The filing discloses that abstentions and broker non-votes will effectively count against approval, which underscores the importance of shareholder participation and the potential effect of broker voting policies. Investors should weigh the benefits of meeting efficiency and avoiding failed votes against the concentration of scheduling discretion in the board; robust disclosure and clear timelines for any adjournment can mitigate governance concerns. Given the company’s small size and thin investor base, the board may reasonably need this authority to secure a quorum or sufficient approval for governance actions. Overall, the proposal is a standard procedural request, but it carries practical implications for shareholder voting power and the timeline for vote finality.